Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Colombia at the centre of preclinical AD research.

[No authors listed]

Lancet Neurol. 2012 Jul;11(7):567. doi: 10.1016/S1474-4422(12)70144-8. No abstract available.

PMID:
22710749
2.

Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.

Newberg AB, Arnold SE, Wintering N, Rovner BW, Alavi A.

J Nucl Med. 2012 Jun;53(6):902-7. doi: 10.2967/jnumed.111.099606. Epub 2012 May 10.

3.

Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.

Livney MG, Clark CM, Karlawish JH, Cartmell S, Negrón M, Nuñez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE.

Am J Geriatr Psychiatry. 2011 May;19(5):430-9. doi: 10.1097/JGP.0b013e3181f7d881.

4.

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Acta Neuropathol. 2011 May;121(5):597-609. doi: 10.1007/s00401-011-0808-0. Epub 2011 Feb 11.

5.

Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.

Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM, Arnold SE, Trojanowski JQ.

Arch Neurol. 2010 Oct;67(10):1238-50. doi: 10.1001/archneurol.2010.254.

6.

Is there pure vascular dementia in old age?

Jellinger KA, Attems J.

J Neurol Sci. 2010 Dec 15;299(1-2):150-4. doi: 10.1016/j.jns.2010.08.038. Epub 2010 Sep 25.

PMID:
20869729
7.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

8.

Prevalence of dementia in Puerto Rican veterans is higher than in mainland U.S. veterans.

Carrión-Baralt JR, Suárez-Pérez E, del Rio R, Moore K, Silverman JM.

J Am Geriatr Soc. 2010 Apr;58(4):798-9. doi: 10.1111/j.1532-5415.2010.02789.x. No abstract available.

9.

Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale.

Xie SX, Ewbank DC, Chittams J, Karlawish JH, Arnold SE, Clark CM.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):268-74. doi: 10.1097/WAD.0b013e318194a324.

10.

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

11.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 May 1;45(4):1107-16. doi: 10.1016/j.neuroimage.2008.12.072. Epub 2009 Jan 21.

12.

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.

13.

Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.

Larner AJ, Doran M.

J Alzheimers Dis. 2009;17(2):259-65. doi: 10.3233/JAD-2009-1042. Review.

PMID:
19221408
14.

Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.

Cercy SP, Sadowski MJ, Wisniewski T.

Cogn Behav Neurol. 2008 Sep;21(3):190-5. doi: 10.1097/WNN.0b013e31817d74bf.

15.

Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM.

Neuroimage. 2008 Jul 15;41(4):1220-7. doi: 10.1016/j.neuroimage.2008.03.050. Epub 2008 Apr 8.

16.

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, Weintraub S, Bigio EH.

Ann Neurol. 2008 Jun;63(6):709-19. doi: 10.1002/ana.21388.

17.

Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Lee JH, Barral S, Cheng R, Chacon I, Santana V, Williamson J, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Stern Y, Tycko B, Rogaeva E, Wakutani Y, Kawarai T, St George-Hyslop P, Mayeux R.

Neurogenetics. 2008 Feb;9(1):51-60. Epub 2007 Oct 17.

18.

A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis.

Shrimpton AE, Schelper RL, Linke RP, Hardy J, Crook R, Dickson DW, Ishizawa T, Davis RL.

Neuropathology. 2007 Jun;27(3):228-32.

PMID:
17645236
19.

Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D.

Arch Neurol. 2006 Mar;63(3):370-6.

20.

Earlier Alzheimer onset in Latino persons: ethnic difference vs selection bias.

Ringman JM, Flores DL.

Arch Neurol. 2005 Nov;62(11):1786-7. No abstract available.

PMID:
16286560

Supplemental Content

Support Center